Person Photo
Person Photo

Loren Hulse


222 South Main Street, Suite 2200, Salt Lake City, UT 84101

Loren delivers sophisticated counsel in the creation, management, and protection of domestic and foreign patent and trademark portfolios to companies disrupting the life sciences, chemical, pharmaceutical, biotech, manufacturing, and medical device industries.

From his experience working as former in-house intellectual property counsel for NPS Pharmaceuticals and as patent counsel for Ceramatec, Inc., Loren understands the business imperative to create robust protection strategies while managing patent and trademark portfolios that align with corporate priorities.

As a practitioner, Loren has developed, managed, and protected both large and small domestic and foreign patent and trademark portfolios. His wide-ranging biotech and pharmaceutical experience includes advising clients how to protect small molecule and peptide drugs, methods of treatment, genetic constructs and therapies, nucleotide analogs, and RNA-related drug technologies. He has also counseled clients developing medical devices such as optically-guided feeding tubes, injectors, diagnostic kits, catheters, and cardiac assist devices. In the chemical arena, Loren’s experience includes assisting clients to protect solid oxide fuel cell technologies, ionically-conductive membrane applications, and syngas production techniques.

Before joining Holland & Hart, Loren was a partner at Stoel Rives, where he served as the co-leader of the firm’s Life Sciences industry group.


Patent Prosecution and Portfolio Management
  • Patent portfolio development and management
  • Domestic and international patent preparation and prosecution
Patent Opinions and Counseling
  • Patent infringement and validity analysis
  • Non-infringement/invalidity opinions
  • Product design counseling
Patent Licensing and Due Diligence
  • Licensing negotiations and strategies
  • Strategic patent acquisitions
  • Product clearances
  • IP due diligence
Trademark Prosecution and Portfolio Management
  • Strategic trademark portfolio management
  • Trademark enforcement strategies
  • Due diligence and acquisition counseling
  • Strategic trademark portfolio management
  • Trademark licensing and transactions


Small molecule and peptide drugs, RNA therapeutics, methods of treatment, genes, genetic constructs and therapies, and nucleotide analogs.

Medical Devices

Optically-guided feeding tubes, injectors devices, diagnostic kits, catheters, infusion therapy, and cardiac assist devices.


Solid oxide fuel cell technologies, ionically conductive membrane applications, and syngas production techniques.



Speaking Engagements


Bar Admissions


  • The Best Lawyers in America®, Patent Law, 2014-2023
  • Utah Business Magazine, Utah Legal Elite, Intellectual Property, 2007-2009, 2011, 2017-2022
  • IAM Patent 1000 – The World's Leading Patent Practitioners, Prosecution – Recommended, 2019-2022
  • IAM Strategy 300
    • The World’s Leading IP Strategists, 2021
    • Strategy 300 Global Leaders, 2022
  • Mountain States Super Lawyers® Rising Stars, 2008-2014
  • Chambers USA, Intellectual Property, 2020, 2022; Up and Coming, 2020

Professional and Civic Affiliations

  • American Intellectual Property Law Association, Member

Unless you are a current client of Holland & Hart LLP, please do not send any confidential information by email. If you are not a current client and send an email to an individual at Holland & Hart LLP, you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us, unless we have already agreed to represent you or we later agree to do so. Thus, we may represent a party adverse to you, even if the information you submit to us could be used against you in a matter, and even if you submitted it in a good faith effort to retain us.